7th Leducq Network Virtual Meeting on Dec/12/2022

Start @ 09:30 Portland, 11:30 Nashville, 12:30 Baltimore, 18.30 Aarhus/Lausanne, 03:30 Brisbane (Tuesday morning, Stowasser group not expected to attend until 6am local)

Time: Dec 12, 2022 11:30 AM Central Time (US and Canada)

Join Zoom Meeting https://zoom.us/j/95509361490

NOTE. TIME ALLOCATION INCLUDES Q&A

12:30-13:25 Baltimore time (18.30 – 19.25 Europe). Welling group (Johns Hopkins)

12:30-12:50 Rick Grimm, Ph.D. Finding the Sweet Spot, Updates

12:50-13:10 Hyun Jun Jung, Ph.D. Updates on DCT remodeling, Finding TF treasures

13:10-13:25 Paul Welling, MD; Summary and plans

Open discussion and break

13:30-14:10 Baltimore time (19.30 – 20.10 Europe). Delpire group (Vanderbilt)

13:30 – 13:50 Eric Delpire, Ph.D: Revisiting the regulation of NCC

13:50 – 14:10 Mohammed Ferdaus, Ph.D. KCC3a and K+ loss in alkalemia

Open discussion and break

14:15-14:45 Baltimore time (20.15 – 20.45 Europe): Fenton group (Aarhus)

14:15-14:30 Søren Poulsen, Ph.D. Glucagon activates NCC in a glucagon receptor-dependent manner

14:30-14:45 Robert Fenton, Ph.D. Summary and plans

Open discussion and break

15:00-15:45 Baltimore time (21.00 – 21.45 Europe). Staub group (Lausanne)

15:00 – 15:20 Olivier Staub, Ph.D. The role of mineralocorticoid receptor in the potassium switch: effect on NCC regulation

15:20-15:40 Alessandro Marazza, PhD. Dissecting the role of PIM kinases in the kidney

Open discussion and break

15:45-16:30 Baltimore time (21.45 – 22.30 Europe). Ellison group (OHSU)

15:00-15:05 Ellison: Introduction

15:05-15:30 Xiao-Tong Su, Ph.D. Post-doctoral fellow,

Four weeks of dietary potassium restriction causes distal convoluted tubule

16:30-17:15 Baltimore time (22.30 – 23.15 Europe, 07.00 – 08.30 Brisbane). Stowasser group

16:30-16:50 Aihua (Nicole) Wu, Ph.D Clinical studies on potassium in hypertension: progress since Boston

16:50-17:10 Michael Stowasser MD. Clinical studies on potassium in hypertension: proposed studies for 2023

3rd Virtual Leducq Association talked Series on Thursday Sep/22

Investigating the A-Kinase anchoring protein 2 (AKAP2) role in the kidney and its potential involvement in acid-base homeostasis

Houwayda Belaid (University of Lausanne)

 

A core regulatory axis of DCT for structural remodeling in response to furosemide

Hyun Jun Jung, PhD (Johns Hopkins)

Leducq Network Meeting in Boston, MA on June/9-June/10/2022

2nd Virtual Leducq Association meeting on Thursday Apr/22

Update on chronic Keffects on Blood Pressure

Robert Little, PhD (Aarhus University)

Utilizing Chemogenetic Tools to Study Distal Convoluted Tubule Function

Tanner Bradford (Oregon Health Science University)

1st Virtual Leducq Association talked Series on Thursday March/17

The Aldosterone Sweet Spot

Rick Grimm, PhD (Johns Hopkins University, Baltimore)

A role for KCC3a in Pendrin regulation and Cl homeostasis?

Mohammed Ferdaus, PhD (Vanderbilt University, Nashville)

Sixth Leducq Network Talk on Thursday Sep/02

NCC and human hypertension

Michael Stowasser, MD

Sixth Leducq Network Summer meeting was held on June28-29 by Zoom.

Fifth Leducq Network Talk on Thursday Jun/03

Aldosterone-dependent signaling networks controlling potassium homeostasis

Olivier Staub, PhD

Fourth Leducq Network Talk on Thursday May/06

The pseudokinase KS-WNK1: activator, inhibitor, or both

David Ellison, MD

Third Leducq Network Talk on March/04

NCC regulation by ubiquitin ligases

Rob Fenton, PhD.